DIEBOLD NIXDORF, Inc (DBD) is a Technology stock tracked by StreetAlpha. It last closed at $52.82 on Nov 17, down 0.21% on the day. DBD reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 2 analysts is $85.00 (+60.9% from the last close), with a high of $90.00 and a low of $80.00.
Only 2 firms rated DBD in the past 90 days, not enough for a consensus
Average 12-month target
$85.00
▲ 60.9% upside
Based on 2 analysts who set a price target on DBD in the past 90 days. The average target is $85.00, with a high of $90.00 and a low of $80.00, compared with the last close of $52.82.
Low $80.00Avg $85.00High $90.00
Blue marker: last close $52.82
Highest target$90.00
Average target$85.00
Lowest target$80.00
Latest rating changes
DA DavidsonTarget lowered
Nov 12Buy$100 → $80
WedbushMaintained
Oct 29Buy$90
DA DavidsonMaintained
Oct 27Buy$100
Date
Firm
Action
Rating
Price target
Nov 12
DA Davidson
Target lowered
Buy
$100 → $80
Oct 29
Wedbush
Maintained
Buy
$90
Oct 27
DA Davidson
Maintained
Buy
$100
Loading…
Whale Options Flow
90D
No whale options trades in DBD in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DBD is in one of them and how their past DBD trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.